Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Hydrogen Water Protects Against Deadly Transplant Complication in Mice

Administration of Hydrogen-Rich Saline Protects Mice From Lethal Acute Graft-Versus-Host Disease (aGVHD)

Research hubs: Immune System

This research was done in animals. Results in animals often don't carry over to people.

Scientific visualization of hydrogen therapy research for Administration of Hydrogen-Rich Saline Protects Mice From Lethal Acute Graft-Versus-Host Disease (aGVHD)
Evidence type
Animal study (mouse)
Journal
Transplantation
Year
2013
Study Type
Mouse
Delivery
Saline (Dissolved)
Outcome
Positive
Peer Reviewed
Yes
Cited by
21 (OpenAlex, as of November 2026)
Country
China

TL;DR

Hydrogen-rich saline may increase survival and improve health in mice after bone marrow transplants that would otherwise cause a deadly immune reaction.

Key Finding

Hydrogen-rich saline increased survival rates and improved clinical symptoms in mice with acute graft-versus-host disease following bone marrow transplantation.

Summary

This study tested whether hydrogen-rich saline (salt water containing dissolved hydrogen gas) could help mice survive acute graft-versus-host disease (aGVHD), a serious complication that occurs after bone marrow transplants when the new immune cells attack the recipient's body. Researchers gave hydrogen-rich saline to mice with aGVHD and found that treated mice had better survival rates, faster recovery of white blood cells, and fewer disease symptoms compared to untreated mice.

Practical Takeaway

While this mouse study suggests hydrogen-rich saline may help protect against graft-versus-host disease complications, it is preliminary research in animals only and has not been tested in humans. Anyone undergoing bone marrow or stem cell transplantation should discuss any potential treatments, including hydrogen water, with their transplant team before use.

Abstract (excerpt)

Allogeneic hematopoietic stem cell transplantation is a potentially curative therapy for many malignant and nonmalignant hematologic diseases. However, acute graft-versus-host disease (aGVHD) is a lethal complication of hematopoietic stem cell transplantation, which limits its application…

Read the full abstract on PubMed